Tille JC - Search Results

1

Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis.

Mandriota SJ, Tenan M, Nicolle A, Jankowska JD, Ferrari P, Tille JC, Durin MA, Green CM, Tabruyn S, Moralli D, Sappino AP. Mandriota SJ, et al. Among authors: tille jc. Int J Mol Sci. 2020 Dec 7;21(23):9332. doi: 10.3390/ijms21239332. Int J Mol Sci. 2020. PMID: 33297592 Free PMC article.

2

Smooth muscle actin isoforms: a tug of war between contraction and compliance.

Arnoldi R, Hiltbrunner A, Dugina V, Tille JC, Chaponnier C. Arnoldi R, et al. Among authors: tille jc. Eur J Cell Biol. 2013 Jun-Jul;92(6-7):187-200. doi: 10.1016/j.ejcb.2013.06.002. Epub 2013 Jul 11. Eur J Cell Biol. 2013. PMID: 23915964

3

Giant mucinous ovarian tumor.

Forster A, Samaras N, Graf C, Tille JC, Samaras D. Forster A, et al. Among authors: tille jc. Am J Med Sci. 2013 May;345(5):400. doi: 10.1097/MAJ.0b013e318251c659. Am J Med Sci. 2013. PMID: 22627266 No abstract available.

4

Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro.

Tille JC, Pepper MS. Tille JC, et al. Exp Cell Res. 2002 Nov 1;280(2):179-91. doi: 10.1006/excr.2002.5635. Exp Cell Res. 2002. PMID: 12413884

5

Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications.

Valence Sd, Tille JC, Chaabane C, Gurny R, Bochaton-Piallat ML, Walpoth BH, Möller M. Valence Sd, et al. Among authors: tille jc. Eur J Pharm Biopharm. 2013 Sep;85(1):78-86. doi: 10.1016/j.ejpb.2013.06.012. Eur J Pharm Biopharm. 2013. PMID: 23958319

6

Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro.

Tille JC, Wang X, Lipson KE, McMahon G, Ferrara N, Zhu Z, Hicklin DJ, Sleeman JP, Eriksson U, Alitalo K, Pepper MS. Tille JC, et al. Exp Cell Res. 2003 May 1;285(2):286-98. doi: 10.1016/s0014-4827(03)00053-3. Exp Cell Res. 2003. PMID: 12706123

7

Lymphangiogenesis and tumor metastasis.

Pepper MS, Tille JC, Nisato R, Skobe M. Pepper MS, et al. Among authors: tille jc. Cell Tissue Res. 2003 Oct;314(1):167-77. doi: 10.1007/s00441-003-0748-7. Epub 2003 Jul 18. Cell Tissue Res. 2003. PMID: 12883995 Review.

8

Role of PAR-4 in ovarian cancer.

Meynier S, Kramer M, Ribaux P, Tille JC, Delie F, Petignat P, Cohen M. Meynier S, et al. Among authors: tille jc. Oncotarget. 2015 Sep 8;6(26):22641-52. doi: 10.18632/oncotarget.4010. Oncotarget. 2015. PMID: 26246468 Free PMC article.

9

Histologic Assessment of Drug-Eluting Grafts Related to Implantation Site.

Tille JC, de Valence S, Mandracchia D, Nottelet B, Innocente F, Gurny R, Möller M, Walpoth BH. Tille JC, et al. J Dev Biol. 2016 Feb 20;4(1):11. doi: 10.3390/jdb4010011. J Dev Biol. 2016. PMID: 29615579 Free PMC article.

10

Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model.

de Valence S, Tille JC, Mugnai D, Mrowczynski W, Gurny R, Möller M, Walpoth BH. de Valence S, et al. Among authors: tille jc. Biomaterials. 2012 Jan;33(1):38-47. doi: 10.1016/j.biomaterials.2011.09.024. Epub 2011 Sep 21. Biomaterials. 2012. PMID: 21940044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page